WellPoint, one of the nation’s largest health insurance agencies, sparred off against the drug Boniva, which is marketed by Genentech. In 2009, WellPoint made it more difficult for beneficiaries to use Boniva, which is used to treat osteoporosis, after conducting a study on the drug. Sufferers of osteoporosis are primarily women, who...
Read more »
